Causal Model for COVID-19 vaccine effectiveness assessment
Author
Marjan Meurisse, Francisco Estupiñán-Romero, Nina Van-Goethem, Enrique Bernal-Delgado
Published
July 27, 2022
BY-COVID project
BeYond-COVID (BY-COVID) aims to provide comprehensive open data on SARS-CoV-2 and other infectious diseases across scientific, medical, public health and policy domains. It will strongly emphasise mobilising raw viral sequences, helping to identify and monitor the spread of SARS-CoV-2 variants. The project will further accelerate the access to SARS-CoV-2 and COVID-19 data, and the linkage of these data to patient and research data.
To ensure interoperability of national and global efforts, BY-COVID will enable federated data analysis compliant with data protection regulations, harmonise and manage metadata and sample identifiers, and facilitate long-term cataloguing.
Ultimately, it will improve European preparedness for future pandemics, and enhance genomic surveillance and rapid-response capabilities. In addition, BY-COVID serves as a demonstrator of interdisciplinary work across country borders. The project’s outputs will allow scientists across multiple domains (including SMEs and industry) to access varied data, with the potential to generate new knowledge on infectious diseases.
WP5 - Use Cases
Work Package 5 will demonstrate usability of BY-COVID services across disciplines and national borders through continuously evolving demonstrator projects or Use Cases. For instance, the proposed baseline use case will assess the effectiveness of SARS-CoV-2 vaccines against SARS-CoV-2 infection using real-world data, improving the understanding of the determinants of the public health response.
Observational retrospective longitudinal study to assess the effectiveness of the SARS-CoV-2 vaccine(s) preventing SARS-CoV-2 infections using routinely collected demographic, social, health and care data from several European regions.
A causal model was established using Directed Acyclic Graphs (DAGs) to map domain knowledge, theories and assumptions about the causal relationship between exposure and outcome. The DAG developed for the research question of interest is shown below.
This causal model was initially created using the DAGitty online tool v.3.0.1
The structural causal model uses a directed acyclic graph (DAG) to map the causal relation between an intervention (or exposure) and an outcome, in the presence of other relevant entities that can potentially act as confounders.
Show the code
# |label: figure-dag# |fig-width: 12# |fig-cap: COVID-19 vaccine(s) effectiveness causal model.# |fig-subcap: Simple DAG## Plot dagitty object ##### plot(dag)## Plot DAG using ggdag ####ggdag_status(dag, text =FALSE, use_labels ="name",layout ="nicely") +guides(color ="none") +# Turn off legendtheme_dag()
Structural Causal Model (DAG) (complete)
The complete structural model shows which entities we need to adjust for enabling causal inference and estimating the impact of the intervention in terms of the outcome for the population.
Show the code
# |label: figure-dag-adjustment-set# |fig-width: 12# |fig-cap: COVID-19 vaccine(s) effectiveness causal model# |fig-subcap: Complete DAG## Plot Asjustment Set using ggdag ####ggdag_adjust(dag, use_labels ="name", text =FALSE, stylized =TRUE) +theme_dag(legend.position ="bottom")
Minimal adjustment set (entities)
The minimal adjustment set includes the entities required for adjustment in our model.
Show the code
# |label: adjustment-setadjustmentSets(dag, type ='minimal', effect ='total')
All entities in the structural causal model are included in the accompanying common data model (CDM) for the baseline use case.
Footnotes
Johannes Textor, Benito van der Zander, Mark K. Gilthorpe, Maciej Liskiewicz, George T.H. Ellison. Robust causal inference using directed acyclic graphs: the R package ‘dagitty’. International Journal of Epidemiology 45(6):1887-1894, 2016.↩︎